Haematology

Doç. Dr. Aysun Halaçoğlu

Doctor and researcher Medipol Bahçelievler Üniversite Hastanesi İstanbul
İngilizce

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: medipol.com.tr.

  • Akut ve Kronik Lösemiler
  • Lenf Bezi Kanserleri (Lenfomalar)
  • Multipl Miyelom ve Diğer Plazma Hücre Hastalıkları
  • Miyelodisplastik Sendrom
  • Polisitemia Vera / Esansiyel Trombositoz
  • Anemiler
  • Kanama ve Pıhtılaşma Bozuklukları
  • Kemik İliği ve Periferik Yayma İncelenmesi
  • Kemoterapi ve İmmünoterapi Uygulamaları

CV

Education and experience

From source

Doç. Dr. Aysun Halaçoğlu 1980 yılında Merzifon’da doğmuştur. Tıp eğitimini 2004 yılında Ankara Üniversitesi Tıp Fakültesi’nde tamamlayarak Tıp Doktoru; İç Hastalıkları ihtisasını 2011 yılında Ankara Atatürk Eğitim ve Araştırma Hastanesi’nde tamamlayarak İç Hastalıkları Uzmanı; Hematoloji ihtisasını 2014 yılında Ankara Başkent Üniversitesi Tıp Fakültesi’nde tamamlayarak Hematoloji Uzmanı ünvanını almıştır. Şişli Hamidiye Etfal Eğitim ve Araştırma Hastanesi’nde mecburi hizmetini tamamlayan Doç. Dr. Aysun Halaçoğlu hematoloji alanında çalışmalarına devam ederek 2024 yılında kemik iliği nakil sertifikasını ve doçentlik ünvanını almıştır. Doç. Dr. Aysun Halaçoğlu halen Medipol Bahçelievler Üniversite Hastanesinde mevcut klinik deneyimiyle güncel ve bilimsel temelli tedavi yaklaşımı ile hizmet sunmayı amaçlamaktadır.

Experience

  • 2023 - 2024İstanbul Aydın Üniversitesi Florya Medical Park Hastanesimedipol.com.tr
  • 2021 - 2023Medicana Bahçelievler Hastanesimedipol.com.tr
  • 2019 - 2021İstinye Üniversitesi Gaziosmanpaşa Medical Park Hastaneimedipol.com.tr
  • 2018 - 2019Memorıal Şişli Hastanesimedipol.com.tr
  • 2015Şişli Hamidiye Etfal E.A.H.medipol.com.tr

Education

  • 2014Başkent Üniversitesi Tıp Fakültesi, Hematoloji Uzmanlık Eğitimimedipol.com.tr
  • 2011Atatürk Eğitim ve Araştırma Hastanesi, İç Hastalıkları Uzmanlık Eğitimimedipol.com.tr
  • 2004Ankara Üniversitesi, Tıp Fakültesimedipol.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyHaematologymedipol.com.trFrom source
  • InstitutionMedipol Bahçelievler Üniversite Hastanesimedipol.com.trFrom source
  • Publications41 publicationsOpenAlexFrom source
  • Languagesİngilizcemedipol.com.trFrom source
  • Last synchronised4 November 2026 20:19https://medipol.com.tr/doktorlarimiz/docdr-aysun-halacoglumedipol.com.tr

Scientific work

Publications

41 publications
Publications by year Most: 4, in 2023
  1. 2012: 1 publication
  2. 2013: 0 publications
  3. 2014: 1 publication
  4. 2015: 0 publications
  5. 2016: 0 publications
  6. 2017: 0 publications
  7. 2018: 0 publications
  8. 2019: 0 publications
  9. 2020: 0 publications
  10. 2021: 1 publication
  11. 2022: 1 publication
  12. 2023: 4 publications
  13. 2024: 1 publication
  14. 2025: 1 publication
  1. ABO incomplete antibodies for COVID-19

    Experimental Biomedical Research, 2025

    DOI 10.30714/j-ebr.2025.234 Source: OpenAlex

  2. Extranodal T/NK lymphoma nasal type: A case with thrombotic thrombocytopenic purpura-like syndrome and third cranial nerve palsy

    Journal of Hematology and Allied Sciences, 2024

    DOI 10.25259/jhas_22_2024 Source: OpenAlex

  3. Peripheral blood stem cells mobilization in patients with relapsed or refractory lymphomas: A single-center experience

    Journal of Cancer Research and Therapeutics, 2023

    DOI 10.4103/jcrt.jcrt_1621_20 PMID 38102912 1 citation (Europe PMC) Source: OpenAlex

  4. Cyclophosphamıde–Etoposıde + G-csf Compared to G-csf alone in Perıpheral Blood Stem Cell Mobılızatıon for Multıple Myeloma

    Hematology and Disorders, 2023

    DOI 10.58489/2836-3582/002 Source: OpenAlex

  5. Associations between M-protein and bone marrow fibrosis in newly diagnosed multiple myeloma

    Journal of Hematology and Allied Sciences, 2023

    DOI 10.25259/jhas_24_2022 Source: OpenAlex

  6. Effect of Mannose-Binding Lectin Gene Polymorphism on Infection in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

    Istanbul Medical Journal, 2023

    DOI 10.4274/imj.galenos.2023.24808 Source: OpenAlex

  7. Relationship between first-line treatment response and bone marrow fibrosis in newly diagnosed multiple myeloma

    Journal of Hematology and Allied Sciences, 2022

    DOI 10.25259/jhas_30_2021 Source: OpenAlex

  8. A Retrospective Comparison of Mitoxantrone-Melphalan and BEAM Conditioning Regimens Before Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Lymphoma Patients

    Indian Journal of Hematology and Blood Transfusion, 2021

    DOI 10.1007/s12288-021-01439-4 PMID 35125716 Open-access full textSource: OpenAlex

  9. Prognostic Factors for Survival of Elderly Patients with Acute Myeloid Leukemia after Intensive Chemotherapy: Validation of 3 Popular Prognostic Models

    Blood, 2014

    DOI 10.1182/blood.v124.21.5332.5332 Source: OpenAlex

  10. Erythema Annulare Centrifugum and Relapsing Polychondritis Associated with Acute Myeloid Leukemia: A Case Report

    Turkish Journal of Hematology, 2012

    DOI 10.5505/tjh.2012.66563 Open-access full textSource: OpenAlex

View all 41 publications